Mayo Clinic Platform has announced it is working with a Utah-based company called Techcyte on the creation of a digital pathology platform.
The organizations claim this digital pathology platform will fundamentally reshape the next generation of pathology services with an open, end-to-end, artificial intelligence-driven solution. The platform is being designed to enable healthcare organizations to economically digitize their pathology practices and use innovative technical and AI workflow solutions.
"Our collaboration with Techcyte will produce a global digital pathology platform, bringing together privacy-protected data sources, solution developers, and caregivers," said John Halamka, M.D., president of Mayo Clinic Platform, in a statement.
The software as a service-based digital pathology platform is an extension of Techcyte's clinical pathology platform. The idea is to create an open AI-enabled anatomic pathology ecosystem that is standards-driven and workflow-focused. Mayo Clinic Platform said the digital pathology platform would enable the integration of a diverse community of pathologists, laboratory information system (LIS) vendors, whole slide scanner manufacturers, storage, AI providers, biopharma, and labs.
"This will be the only platform in the world that unites clinical and anatomic pathology into one solution that improves the lives of pathologists, their clinical colleagues, and the patients they serve,” said Ben Cahoon, CEO of Techcyte, in a statement.
This new effort builds upon a clinical pathology collaboration between Mayo Clinic and Techcyte to digitize diagnostic testing in lab medicine. "This new collaboration is exciting," says Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, in a statement. "The combination of Mayo Clinic's diagnostic expertise with Techcyte's digital workflows will shape the future of both the clinical and anatomical pathology practices."
